Modeling the human kinetic adjustment factor for inhaled volatile organic chemicals: Whole population approach versus distinct subpopulation approach

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  Valcke, M ^a,b   Nong, A ^a   Krishnan, K ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; DIOXANE; VOLATILE ORGANIC COMPOUND;

ADJUSTMENT; ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; BLOOD; CANADA; CHILD; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; INFANT; LITERATURE; METABOLIC RATE; NEWBORN; POPULATION; PREGNANT WOMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

EID: 84859735364     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/404329     Document Type: Article

References (44)

1. Dourson M. L., Felter S. P., Robinson D., Evolution of science-based uncertainty factors in noncancer risk assessment Regulatory Toxicology and Pharmacology 1996 24 2 108 120
2. Dourson M. L., Stara J. F., Regulatory history and experimental support of uncertainty (safety) factors Regulatory Toxicology and Pharmacology 1983 3 3 224 238 (Pubitemid 14229334)
3. U.S.EPA., A review of the reference dose and reference concentration process. Risk Assessment Forum. EPA/630/P-02/00F. Washington, DC, USA, 2002
4. Price P. S., Keenan R. E., Schwab B., Defining the interindividual (intraspecies) uncertainty factor Human and Ecological Risk Assessment 1999 5 5 1023 1033 (Pubitemid 129725207)
5. Dorne J. L. C. M., Renwick A. G., The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans Toxicological Sciences 2005 86 1 20 26 (Pubitemid 41511345)
6. IPCS, Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health Based Exposure Limits 1994 Geneva, Switzerland World Health Organization, International Panel on Chemical Safety. Environmental Health Criteria
7. Renwick A. G., Lazarus N. R., Human variability and noncancer risk assessmentan analysis of the default uncertainty factor Regulatory Toxicology and Pharmacology 1998 27 1 I 3 20 (Pubitemid 28289017)
8. IPCS, Chemical-Specific Adjustment Factors (CSAFs) for Interspecies Differences and Human Variability: Guidance Document for the Use of Data in Dose/Concentration-Response Assessment 2005 Geneva, Switzerland WHO
9. Meek M. E., Renwick A., Ohanian E., Dourson M., Lake B., Naumann B. D., Vu V., Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment Toxicology 2002 181-182 115 120 (Pubitemid 36015683)
10. U.S.EPA., Integrated Risk Information System. U.S. Environmental Protection Agency, Washington, DC, USA, 2010
11. Ginsberg G., Hattis D., Sonawane B., Russ A., Banati P., Kozlak M., Smolenski S., Goble R., Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature Toxicological Sciences 2002 66 2 185 200 (Pubitemid 34285113)
12. Dorne J. L. C. M., Walton K., Renwick A. G., Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review Food and Chemical Toxicology 2005 43 2 203 216 (Pubitemid 40037938)
13. Dorne J. L. C. M., Human variability in hepatic and renal elimination: implications for risk assessment Journal of Applied Toxicology 2007 27 5 411 420 (Pubitemid 47255493)
14. Nong A., McCarver D. G., Hines R. N., Krishnan K., Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene Toxicology and Applied Pharmacology 2006 214 1 78 87 (Pubitemid 43867671)
15. Valcke M., Krishnan K., Evaluation of the impact of the exposure route on the human kinetic adjustment factor Regulatory Toxicology and Pharmacology 2011 59 2 258 269
16. Valcke M., Krishnan K., An assessment of the impact of physico-chemical and biochemical characteristics on the human kinetic adjustment factor for systemic toxicants Toxicology 2011 286 13 36 47
17. Mrk A. K., Johanson G., Chemical-specific adjustment factors for intraspecies variability of acetone toxicokinetics using a probabilistic approach Toxicological Sciences 2010 116 1 336 348
18. Ronis M. J. J., Lindros K. O., Ingelman-Sundberg M., Ioannides C., The CYP2E family Cytochrome P450 Metabolic and Toxicological Aspects 1996 Boca Raton, Fla, USA CRC Press 211 240
19. Johnsrud E. K., Koukouritaki S. B., Divakaran K., Brunengraber L. L., Hines R. N., McCarver D. G., Human hepatic CYP2E1 expression during development Journal of Pharmacology and Experimental Therapeutics 2003 307 1 402 407 (Pubitemid 37151933)
20. Lipscomb J. C., Teuschler L. K., Swartout J. C., Striley C. A. F., Snawder J. E., Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver Toxicology Mechanisms and Methods 2003 13 1 45 51 (Pubitemid 36262366)
21. Nannelli A., De Rubertis A., Longo V., Gervasi P. G., Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat Archives of Toxicology 2005 79 2 74 82 (Pubitemid 40311559)
22. Haddad S., Béliveau M., Tardif R., Krishnan K., A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures Toxicological Sciences 2001 63 1 125 131 (Pubitemid 32799032)
23. Reitz R. H., McCroskey P. S., Park C. N., Andersen M. E., Gargas M. I., Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane Toxicology and Applied Pharmacology 1990 105 1 37 54 (Pubitemid 20287022)
24. Andersen M. E., Pharmacokinetics of inhaled gases and vapors Neurobehavioral Toxicology and Teratology 1981 3 4 383 389 (Pubitemid 12143984)
25. Chiu W. A., White P., Steady-state solutions to PBPK models and their applications to risk assessment I: route-to-route extrapolation of volatile chemicals Risk Analysis 2006 26 3 769 780 (Pubitemid 43944591)
26. Csandy G. A., Filser J. G., The relevance of physical activity for the kinetics of inhaled gaseous substances Archives of Toxicology 2001 74 11 663 672 (Pubitemid 32208892)
27. Pelekis M., Krewski D., Krishnan K., Physiologically based algebraic expressions for predicting steady-state toxicokinetics of inhaled vapors Toxicology Methods 1997 7 3 205 225
28. Price P. S., Conolly R. B., Chaisson C. F., Gross E. A., Young J. S., Mathis E. T., Tedder D. R., Modeling interindividual variation in physiological factors used in PBPK models of humans Critical Reviews in Toxicology 2003 33 5 469 503 (Pubitemid 37268185)
29. ICRP, Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89 Annals of the ICRP 2002 32 3-4 5 265
30. Statistiques Canada, Estimations de la population selon le sexe et le groupe d'ge au 1er juillet 2010, Canada http://www.statcan.gc.ca/daily- quotidien/100929/t100929b4-fra.htm
31. Ventura S. J., Abma J. C., Mosher W. D., Henshaw S. K., Estimated pregnancy rates by outcome for the United States, 19902004 National Vital Statistics Reports 2008 56 15 1 28
32. Jamei M., Dickinson G. L., Rostami-Hodjegan A., A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of 'bottom-up' vs 'top-down' recognition of covariates Drug Metabolism and Pharmacokinetics 2009 24 1 53 75
33. Hudachek S. F., Gustafson D. L., Customized in silico population mimics actual population in docetaxel population pharmacokinetic analysis Journal of Pharmaceutical Sciences 2011 100 3 1156 1166
34. Brochu P., Ducré-Robitaille J. F., Brodeur J., Physiological daily inhalation rates for free-living pregnant and lactating adolescents and women aged 11 to 55 years, using data from doubly labeled water measurements for use in health risk assessment Human and Ecological Risk Assessment 2006 12 4 702 735 (Pubitemid 44274865)
35. Brochu P., Brodeur J., Krishnan K., Derivation of physiological inhalation rates in children, adults, and elderly based on nighttime and daytime respiratory parameters Inhalation Toxicology 2011 23 2 74 94
36. Faustman E. M., Ribeiro P., Hood R. D., Pharmacokinetic consideration in developmental toxicity Developmental Toxicology: Risk Assessment and the Future 1990 New York, NY, USA D. Van Nostrand Reinhold Company 109 136
37. Price K., Haddad S., Krishnan K., Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children Journal of Toxicology and Environmental HealthPart A 2003 66 5 417 433 (Pubitemid 36269795)
38. Sarangapani R., Robinan Gentry P., Covington T. R., Teeguarden J. G., Clewell H. J., Evaluation of the potential impact of age- and gender-specific lung morphology and ventilation rate on the dosimetry of vapors Inhalation Toxicology 2003 15 10 987 1016 (Pubitemid 37158651)
39. WHO, Principles for Evaluating Health Risks in Children Associated with Exposure to Chemicals 2006 Geneva, Switzerland World Health Organization Environmental Health Criteria 237
40. Pelekis M., Gephart L. A., Lerman S. E., Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds Regulatory Toxicology and Pharmacology 2001 33 1 12 20 (Pubitemid 32242943)
41. Pelekis M., Nicolich M. J., Gauthier J. S., Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors Risk Analysis 2003 23 6 1239 1255 (Pubitemid 38045103)
42. Haber L. T., Maier A., Gentry P. R., Clewell H. J., Dourson M. L., Genetic polymorphisms in assessing interindividual variability in delivered dose Regulatory Toxicology and Pharmacology 2002 35 2 I 177 197 (Pubitemid 34664919)
43. Clewell H. J., Gentry P. R., Covington T. R., Sarangapani R., Teeguarden J. G., Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry Toxicological Sciences 2004 79 2 381 393 (Pubitemid 38786895)
44. Neafsey P., Ginsberg G., Hattis D., Johns D. O., Guyton K. Z., Sonawane B., Genetic polymorphism in CYP2E1: population distribution of CYP2E1 activity Journal of Toxicology and Environmental HealthPart B 2009 12 5-6 362 388